Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ovid Therapeutics (OVID) Other financing activities (2020 - 2022)

Historic Other financing activities for Ovid Therapeutics (OVID) over the last 3 years, with Q4 2022 value amounting to -$56943.0.

  • Ovid Therapeutics' Other financing activities fell 7111.3% to -$56943.0 in Q4 2022 from the same period last year, while for Sep 2022 it was $23665.0, marking a year-over-year decrease of 9000.75%. This contributed to the annual value of $21314.0 for FY2021, which is 8694.4% down from last year.
  • According to the latest figures from Q4 2022, Ovid Therapeutics' Other financing activities is -$56943.0, which was down 7111.3% from $41023.0 recorded in Q3 2022.
  • In the past 5 years, Ovid Therapeutics' Other financing activities registered a high of $182236.0 during Q4 2020, and its lowest value of -$56943.0 during Q4 2022.
  • Its 3-year average for Other financing activities is $16778.5, with a median of -$540.0 in 2020.
  • Its Other financing activities has fluctuated over the past 5 years, first soared by 1522814.81% in 2021, then tumbled by 12019.8% in 2022.
  • Quarter analysis of 3 years shows Ovid Therapeutics' Other financing activities stood at $182236.0 in 2020, then crashed by 118.26% to -$33278.0 in 2021, then plummeted by 71.11% to -$56943.0 in 2022.
  • Its Other financing activities was -$56943.0 in Q4 2022, compared to $41023.0 in Q3 2022 and $20225.0 in Q2 2022.